During the past years, we have witnessed continued growth and expansion of our clinical, education, research, and service missions, working in coordination with the strategic goals of the University of Florida. Our department has been central to several of the top priorities for the university-wide strategic plan including, neurosciences, genetics, cancer, and children/family issues.
In education, the UF Department of Pediatrics has attracted UF medical students to the field of pediatrics at twice the national rate. We have provided outstanding training to pediatric residents, whose average scores for board certification are more than 100 points above the national average.
In patient care, the Department of Pediatrics has established the UF Health Shands Children’s Hospital as a hospital within a hospital on the UF Health campus. We have accomplished numerous clinical firsts, including being the first to perform pediatric heart and lung transplants in the state, the first to bring cutting edge nitric oxide therapy into use in respiratory failure, the first to transplant umbilical cord blood stem cells for patients with leukemia and primary immune deficiency.
In research, the Department of Pediatrics has increased its rate of nationally competitive funding from the National Institutes of Health (NIH) by tenfold over the past ten years, including research in areas as diverse as HIV/AIDS research, epilepsy and seizure prediction, gene therapy for heart failure and lung disease, genetic obesity syndromes, juvenile diabetes, prenatal and postnatal nutrition, and nerve cell tumors.
Welcome to the University of Florida Health 2020 Pediatric Progress Report, where we share news and updates from UF Health Shands Children’s Hospital. Read more about what makes our pediatric programs unique and contributes to our success as one of the nation’s best children’s hospitals. We hope you will appreciate our digital format, which is best viewed using Firefox or Chrome from a PC or Safari from a Mac.